| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/29/2009 | US7595319 Compounds having selective inhibiting effect at GSK3 |
| 09/29/2009 | US7595318 Conjugates which bind VLA-4; may also inhibit leukocyte adhesion; useful in the treatment of inflammatory diseases in a mammalian patient, such as asthma, Alzheimer's disease, atherosclerosis, AIDS, dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis |
| 09/29/2009 | US7595317 Antiarthritic agents; rheumatoid and osteoarthritis; corneal, epidermal, or gastric ulceration; tumor metastasis or invasion; periodontal disease; and bone disease; 4-[(2-methyl-4-quinolinyl)methoxy]-N-(1,3,5-trioxo-2,4-diazaspiro[5.5]undec-7-yl)benzamide trifluoroacetate, for example |
| 09/29/2009 | US7595315 Morpholine derivatives as norepinephrine reuptake inhibitors |
| 09/29/2009 | US7595312 (1) (S)-2-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dione, for example; treatment of headaches, particularly migraine or cluster headaches |
| 09/29/2009 | CA2550372C Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 09/29/2009 | CA2521391C Potassium salt of s-omeprazole as intermediate in the preparation of the magnesium salt of s-omeprazole trihydrate |
| 09/29/2009 | CA2484460C Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-yl]-1-piperidinyl]ethyl]-.alpha..alpha. dimethyl-benzeneacetic acid |
| 09/29/2009 | CA2375670C 5-phenyl-pyrimidine derivatives |
| 09/29/2009 | CA2371853C Heterocyclic benzenesulphonamide compounds as bradykinin antagonists |
| 09/29/2009 | CA2315647C Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas |
| 09/29/2009 | CA2293433C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors |
| 09/24/2009 | WO2009117676A2 Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase |
| 09/24/2009 | WO2009117269A1 Substituted 4-hydroxypyrimidine-5-carboxamides |
| 09/24/2009 | WO2009117109A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 09/24/2009 | WO2009116072A2 Process for preparation of pyridinylmethylsulphinyl benzimidazole compounds and pyridine intermediates |
| 09/24/2009 | WO2009116067A2 Novel derivatives of acyl cyanopyrrolidines |
| 09/24/2009 | WO2009115685A1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof. |
| 09/24/2009 | WO2009115665A1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors |
| 09/24/2009 | WO2009115572A2 Novel heterocyclic compounds and uses therof |
| 09/24/2009 | WO2009115562A2 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts |
| 09/24/2009 | WO2009115558A1 Fungicide hydroximoyl-tetrazole derivatives |
| 09/24/2009 | WO2009115557A2 Fungicide hydroximoyl-tetrazole derivatives |
| 09/24/2009 | WO2009115556A1 Fungicide hydroximoyl-tetrazole derivatives |
| 09/24/2009 | WO2009115547A1 Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators |
| 09/24/2009 | WO2009115517A2 Organic compounds |
| 09/24/2009 | WO2009115486A1 Triazole amide derivatives for use in therapy |
| 09/24/2009 | WO2009115427A1 Pyrrolidinyl derivatives and uses thereof |
| 09/24/2009 | WO2009115257A1 Substituted sulfonamide derivatives |
| 09/24/2009 | WO2009114994A1 The use of the pyridazinone derivatives for the manufacture of medicament for anti-tumour |
| 09/24/2009 | WO2009114981A1 Process for preparing sulfoxide compounds |
| 09/24/2009 | WO2009087212A3 Pyridine derivatives |
| 09/24/2009 | WO2009075923A3 6, 11-bridged biaryl macrolides |
| 09/24/2009 | WO2009065921A3 Novel compounds |
| 09/24/2009 | WO2009057139A3 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 09/24/2009 | WO2009032668A3 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 09/24/2009 | WO2009024611A3 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use |
| 09/24/2009 | WO2009005674A3 Novel hiv reverse transcriptase inhibitors |
| 09/24/2009 | WO2008146297A3 Improved process for amorphous rabeprazole sodium |
| 09/24/2009 | WO2008142006A9 Process for preparing 2-(2-pyridylmethyl)-sulfinyl-1h-benzimidazoles and the intermediate compounds used therein |
| 09/24/2009 | WO2008035378A3 An improved process for the preparation of thalidomide |
| 09/24/2009 | WO2008001392A3 An improved process for the preparation of pantoprazole and its pharmaceutically acceptable salts |
| 09/24/2009 | US20090240058 Activator for Peroxisome Proliferator-Activating Receptor Delta |
| 09/24/2009 | US20090240056 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 09/24/2009 | US20090239911 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/24/2009 | US20090239906 Alkoxyalkyl-substituted cyclic ketoenols |
| 09/24/2009 | US20090239905 Piperidines and related compounds for the treatment of dementia |
| 09/24/2009 | US20090239903 Tetrahydroquinoline analogues as muscarinic agonists |
| 09/24/2009 | US20090239890 Spiro substituted cyclopropane compounds for the treatment of inflammatory disorders |
| 09/24/2009 | US20090239889 Spiro[2-cyclohexene-1,3'-[3H]indole]-2',4(1'H)-diones and 4-hydroxyspiro[2-cyclohexene-1,3'-[3H]indol]-2'(1'H)-ones; act as antagonists of mdm2 interactions; useful as potent and selective anticancer agents |
| 09/24/2009 | US20090239883 Treatment of Pulmonary Hypertension |
| 09/24/2009 | US20090239880 Combinations of monoamine reuptake inhibitors and potassium channel activators |
| 09/24/2009 | US20090239879 N-oxides of n-phenyl-2-pyrimidine-amine derivatives |
| 09/24/2009 | US20090239877 Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
| 09/24/2009 | US20090239876 Substituted 4-Hydroxypyrimidine-5-Carboxamides |
| 09/24/2009 | US20090239872 Treatment of mesothelioma |
| 09/24/2009 | US20090239866 Peptide deformylase inhibitors |
| 09/24/2009 | US20090239865 Dibenzyl amine compounds and derivatives |
| 09/24/2009 | US20090239863 1-aryl-or 1- alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/24/2009 | US20090239862 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators |
| 09/24/2009 | US20090239861 Quinazoline derivatives as anticancer agents |
| 09/24/2009 | US20090239848 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 09/24/2009 | US20090239847 Organic compounds |
| 09/24/2009 | US20090239845 Pyrazole compounds as prostaglandin receptors ligands |
| 09/24/2009 | US20090239810 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 09/24/2009 | US20090238761 Novel Aryl Piperazine Derivatives With Medical Utility |
| 09/24/2009 | US20090236973 Organic compound, charge-transporting material, and organic electroluminescent element |
| 09/24/2009 | CA2718936A1 Novel heterocyclic compounds and uses therof |
| 09/24/2009 | CA2718736A1 Pyrrolidinyl derivatives and uses thereof |
| 09/24/2009 | CA2718693A1 Substituted pyrazolamides and the use thereof |
| 09/24/2009 | CA2718551A1 Substituted sulfonamide derivatives |
| 09/24/2009 | CA2718528A1 Substituted 4-hydroxypyrimidine-5-carboxamides |
| 09/24/2009 | CA2718526A1 Organic compounds |
| 09/24/2009 | CA2718264A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 09/24/2009 | CA2718076A1 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts |
| 09/24/2009 | CA2716035A1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 09/24/2009 | CA2715272A1 A high throughput protein interaction assay |
| 09/24/2009 | CA2715096A1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors |
| 09/24/2009 | CA2714662A1 Trisubstituted 1,2,4-triazoles as nicotinic acetylcholine receptor modulators |
| 09/23/2009 | EP2103608A1 Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion |
| 09/23/2009 | EP2103603A1 Method for producing pyrrolidine compound |
| 09/23/2009 | EP2102199A1 Antibacterial polycyclic urea compounds |
| 09/23/2009 | EP2102193A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases |
| 09/23/2009 | EP2102192A1 Solid state forms of racemic ilaprazole |
| 09/23/2009 | EP2102191A1 Crystalline forms of solvated ilaprazole |
| 09/23/2009 | EP2102190A1 Compounds and compositions as kinase inhibitors |
| 09/23/2009 | EP2102189A2 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 09/23/2009 | EP2102188A2 Compounds |
| 09/23/2009 | EP2102187A1 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase |
| 09/23/2009 | EP2102186A1 Indoles |
| 09/23/2009 | EP2102185A1 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| 09/23/2009 | EP2102171A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 09/23/2009 | EP2102170A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/23/2009 | EP2102169A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 09/23/2009 | EP2102168A1 Acylaminopyrazoles for treating cardiovascular diseases |
| 09/23/2009 | EP2102157A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 09/23/2009 | EP2101768A2 Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases |
| 09/23/2009 | EP1729818B1 Contrast agents for magnetic resonance imaging |
| 09/23/2009 | EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 09/23/2009 | EP0946508B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |